Methadone Maintenance-lessons from Two Systems in China

Overview

Journal Harm Reduct J

Publisher Biomed Central

Specialties Pharmacology
Psychiatry

Date 2017 Sep 27

PMID 28946906

Citations 2

Authors

Shui-Shan Lee

Robert Newman

Affiliations

Soon will be listed here.

Abstract

In Hong Kong, methadone maintenance treatment (MMT) was launched in the 1970s, almost 30 years before the counterpart programme's inauguration in Mainland China. Both were established in response to perceived public crises-addiction-related crime and HIV outbreak, respectively-and both are now regular services under two systems in the same country. Effectiveness of MMT in achieving the stated goals was evident in each case and provides useful lessons on strategies for dealing with the varied concerns related to illicit drug use. Today, with changing patterns of drug addiction, increasing competition for resources, and changing attitudes towards addiction and its treatment, the two MMT systems are confronted with similar challenges to achieve sustainability.

Citing Articles

Point-of-care hepatitis C reflex testing and treatment referral in methadone clinic settings in Hong Kong-a pilot study.

Wong N, Chan D, Chan C, Poon C, Wong G, Wong V IJID Reg. 2022; 5:8-12.

PMID: 36119439 PMC: 9471432. DOI: 10.1016/j.ijregi.2022.08.007.

Participation pattern of methadone users and its association with social connection and HIV status: Analyses of electronic health records data.

Kwan T, Wong N, Lee S PLoS One. 2019; 14(5):e0216727.

PMID: 31071182 PMC: 6508728. DOI: 10.1371/journal.pone.0216727.

References

Lee S, Newman R . Tribute to Peter Lee, pioneer of methadone treatment in Hong Kong. Int J Drug Policy. 2009; 20(2):99-100. DOI: 10.1016/j.drugpo.2008.12.004. View

DOLE V, NYSWANDER M . A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. JAMA. 1965; 193:646-50. DOI: 10.1001/jama.1965.03090080008002. View

Lee S . A humble service that has delivered public health good. Public Health. 2007; 121(11):884-6. DOI: 10.1016/j.puhe.2007.02.017. View

Tang Y, Zhao D, Zhao C, Cubells J . Opiate addiction in China: current situation and treatments. Addiction. 2006; 101(5):657-65. DOI: 10.1111/j.1360-0443.2006.01367.x. View

Brickner P, Torres R, Barnes M, Newman R, Des Jarlais D, Whalen D . Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users. Ann Intern Med. 1989; 110(10):833-7. DOI: 10.7326/0003-4819-110-10-833. View

Sullivan S, Wu Z, Rou K, Pang L, Luo W, Wang C . Who uses methadone services in China? Monitoring the world's largest methadone programme. Addiction. 2014; 110 Suppl 1:29-39. DOI: 10.1111/add.12781. View

Wong N, Chan P, Lee S, Lee S, Lee C . A multilevel approach for assessing the variability of hepatitis C prevalence in injection drug users by their gathering places. Int J Infect Dis. 2012; 17(3):e193-8. DOI: 10.1016/j.ijid.2012.10.004. View

Zhang Y, Shan H, Trizzino J, Ruan Y, Beauchamp G, Masse B . Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China. J Infect. 2006; 54(3):285-90. DOI: 10.1016/j.jinf.2006.06.001. View

Hesketh T, Zhang J, Qiang D . HIV knowledge and risk behaviour of female sex workers in Yunnan Province, China: potential as bridging groups to the general population. AIDS Care. 2005; 17(8):958-66. DOI: 10.1080/09540120500100676. View

10.

Zheng X, Tian C, Choi K, Zhang J, Cheng H, Yang X . Injecting drug use and HIV infection in southwest China. AIDS. 1994; 8(8):1141-7. DOI: 10.1097/00002030-199408000-00017. View

11.

Yu X, Chen J, Shao Y, Beyrer C, Liu B, Wang Z . Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr. 2000; 22(2):180-8. DOI: 10.1097/00126334-199910010-00011. View

12.

Yin W, Hao Y, Sun X, Gong X, Li F, Li J . Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010; 39 Suppl 2:ii29-37. PMC: 2992615. DOI: 10.1093/ije/dyq210. View

13.

Kwan T, Wong N, Lee S . Participation dynamics of a cohort of drug users in a low-threshold methadone treatment programme. Harm Reduct J. 2015; 12:30. PMC: 4608158. DOI: 10.1186/s12954-015-0072-z. View

14.

Wong K, Lee S, Lim W, Low H . Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. J Subst Abuse Treat. 2003; 24(3):233-9. DOI: 10.1016/s0740-5472(03)00029-1. View

15.

Zhang L, Chow E, Zhuang X, Liang Y, Wang Y, Tang C . Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis. PLoS One. 2013; 8(7):e68906. PMC: 3724877. DOI: 10.1371/journal.pone.0068906. View

16.

Marienfeld C . Heroin addiction, methadone, and HIV in China. Lancet Psychiatry. 2016; 3(9):799-800. DOI: 10.1016/S2215-0366(16)30130-4. View

17.

Zhuang X, Liang Y, Chow E, Wang Y, Wilson D, Zhang L . HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis. 2012; 12:130. PMC: 3434111. DOI: 10.1186/1471-2334-12-130. View

18.

Wang L, Guo W, Li D, Ding Z, McGoogan J, Wang N . HIV epidemic among drug users in China: 1995-2011. Addiction. 2014; 110 Suppl 1:20-8. PMC: 4275840. DOI: 10.1111/add.12779. View

19.

Zhou K, Zhuang G . Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review. Addict Behav. 2013; 39(1):22-9. DOI: 10.1016/j.addbeh.2013.09.001. View

20.

Wu Q, Kamphuis C, Duo L, Luo J, Chen Y, Richardus J . Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities. Harm Reduct J. 2017; 14(1):10. PMC: 5307648. DOI: 10.1186/s12954-017-0137-2. View